[Treatment of XXXX (excluding pregnancy project)].

@entity1 @entity558 @entity1420 @entity1870 @entity1834 @entity2692 @entity7828 @entity1176 @entity931
UNASSIGNED: In this review we aimed to update the possibilities of @entity1870 treatment in @entity1 excluding those with a desire for pregnancy. @entity1870 is defined as the presence of endometrial tissue within the myometrium and frequently underestimated. Over the last decades, its pathophysiology has been better known. The diagnosis is essentially based on clinical symptoms like @entity931 and @entity1834 . Transvaginal ultrasound and magnetic resonance imaging are the main tools of the radiologic diagnosis. However, the definitive diagnosis is histological. The most effective treatment remains hysterectomy; however it is expensive, radical and at risk of morbidity compared with medical or surgical conservative management. The literature has reported several series of @entity1 undergoing various treatments, thus allowing different therapeutic options. The @entity2692 -releasing intrauterine device showed its efficacy alone or in combination with hysteroscopic treatment. Oral @entity7828 , @entity1176 agonists are useful at short term or in @entity558 . Some conservative treatments like focused ultrasound therapies or uterus-sparing operative treatment stay under evaluation and seems to be effective. Embolization has been the subject of several studies and must be outlined. Furthermore, several molecules, such as modulators of @entity1420 receptors and the aromatase inhibitors have been recently studied and are perhaps future treatments.
